Vera Therapeutics Inc

Market Cap

$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$31.75-$16.87 (-34.70%)

Jun 8, 2026

52W High $55.6752W Low $19.25

Company Details

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc...

CEO

—

IPO Date

May 14, 2021

Website

veratx.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$369M

EPS (Diluted)

Free Cash Flow

-$294M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 7, 2026

FY 2025

Feb 26, 2026

Q4 2025

Feb 26, 2026

Q3 2025

Nov 5, 2025

Q2 2025

Aug 5, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee